TD Waterhouse Canada Inc. Sells 30,462 Shares of CVS Health Corporation $CVS

Key Points

• TD Waterhouse Canada Inc. reduced its stake in CVS by 9.1%, selling 30,462 shares and leaving 305,619 shares valued at about $24.25 million at quarter end.
• CVS beat Q4 expectations with $1.09 EPS (vs. $1.00) and $105.69 billion revenue (vs. $103.67B), set FY2026 EPS guidance of 5.94–6.14, and carries a market cap near $99 billion with a consensus "Moderate Buy" and average price target of $95.05.
• The company announced a quarterly dividend of $0.665 (annualized $2.66, yield ~3.4%) but faces near‑term risks including a planned distribution‑center strike and a division entering a Chapter 11 liquidation sale.

TD Waterhouse Canada Inc. reduced its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 9.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 305,619 shares of the pharmacy operator's stock after selling 30,462 shares during the period. TD Waterhouse Canada Inc.'s holdings in CVS Health were worth $24,251,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Harbor Capital Advisors Inc. lifted its stake in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator's stock valued at $26,000 after buying an additional 142 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in shares of CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator's stock valued at $26,000 after buying an additional 281 shares in the last quarter. Corundum Trust Company INC purchased a new stake in shares of CVS Health during the 3rd quarter valued at approximately $29,000. GoalVest Advisory LLC purchased a new stake in shares of CVS Health during the 4th quarter valued at approximately $32,000. Finally, SOA Wealth Advisors LLC. lifted its stake in shares of CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator's stock valued at $37,000 after buying an additional 131 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Stock Performance

NYSE CVS opened at $77.30 on Monday. The company's 50 day simple moving average is $75.98 and its two-hundred day simple moving average is $77.85. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The stock has a market capitalization of $99.06 billion, a PE ratio of 56.01, a P/E/G ratio of 0.81 and a beta of 0.51. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion for the quarter, compared to analysts' expectations of $103.67 billion. During the same quarter last year, the company posted $1.19 EPS. The business's quarterly revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Investors of record on Thursday, April 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health's dividend payout ratio (DPR) is currently 192.75%.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Baird raised its price target on CVS to $94 from $92 and reiterated an Outperform rating, saying it updated its model and became more constructive on the stock. This analyst upgrade supports upside sentiment. Baird Turns More Bullish on CVS, Nudges Price Target Higher
• Positive Sentiment: Commentary from TV/influential investors (Jim Cramer) highlighting CVS’s advantages (scale across insurance, pharmacy and retail) has supported bullish flows into the stock. Jim Cramer Shares Big Advantage For CVS Health Corporation (CVS)
• Neutral Sentiment: Dividend roundups continue to list CVS among notable dividend-paying healthcare names, keeping income-oriented investors attentive but not necessarily moving price materially. Dividend roundup: Johnson & Johnson, Costco, Caterpillar, CVS Health, and more
• Neutral Sentiment: Q4 earnings roundups show CVS’s insurance and pharmacy segments performed competitively versus peers and management has guided FY2026 EPS (5.94–6.14), which underpins longer‑term expectations even if near‑term volatility persists. Q4 Earnings Roundup: CVS Health And The Rest Of The Health Insurance Providers Segment
• Neutral Sentiment: Articles comparing prescription savings (GoodRx vs. CVS vs. Costco) reinforce competitive dynamics in retail pharmacy pricing — relevant for margins and customer mix but not an immediate catalyst. GoodRx vs. CVS vs. Costco: Where Retirees Save the Most on Prescriptions
• Negative Sentiment: Labor risk: over 500 drivers and warehouse workers at CVS’s Fredericksburg, VA distribution center authorized a strike and the union said workers plan to walk out May 1, raising short‑term supply/distribution disruption risk and potential incremental labor costs. CVS distribution center workers plan to go on strike
• Negative Sentiment: TheStreet reports that a CVS division has entered a Chapter 11 liquidation sale, signaling a sizable (billion‑dollar) issue in a non‑core unit that could weigh on cash flow, legal/administrative costs and investor sentiment until resolved. CVS division enters Chapter 11 liquidation sale

Analysts Set New Price Targets

A number of brokerages recently commented on CVS. Robert W. Baird upped their price target on shares of CVS Health from $92.00 to $94.00 and gave the company an "outperform" rating in a research note on Wednesday, April 15th. Sanford C. Bernstein upgraded shares of CVS Health from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $91.00 to $94.00 in a research note on Thursday, March 12th. Weiss Ratings reiterated a "hold (c-)" rating on shares of CVS Health in a research note on Monday, December 29th. Bank of America lowered their target price on shares of CVS Health from $100.00 to $95.00 and set a "buy" rating on the stock in a research note on Tuesday, January 27th. Finally, Argus lowered their target price on shares of CVS Health from $91.00 to $90.00 and set a "buy" rating on the stock in a research note on Wednesday, January 28th. Twenty equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, CVS Health presently has a consensus rating of "Moderate Buy" and an average price target of $95.05.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.